Clinical Trial Update: BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated adherence to monthly ibandronate (Bonviva) in women with postmenopausal osteoporosis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Postmenopausal Osteoporosis | Phase 4 | Status: COMPLETED